Literature DB >> 23269457

Successful prevention of tunneled central catheter infection by antibiotic lock therapy using cefazolin and gentamicin.

T N V Silva1, M L Mendes, J M G Abrão, J T Caramori, D Ponce.   

Abstract

Catheter-related bacteremia (CRB) is one of the various complications related to hemodialysis (HD). As a result of this high rate of infection, the antibiotic lock technique (ALT) has been recommended to prevent CRB. However, adverse effects of ALT such as increased emergence of strains resistant to antibiotics and increased mechanical dysfunction catheter were poorly evaluated. We prospectively evaluated the efficacy of catheter-restricted filling using an antibiotic lock solution in preventing CRB. A total of 233 HD patients requiring 325 new tunneled catheters while waiting for placement and maturation of an arteriovenous fistula or graft were enrolled in this study. Patients with a tunneled catheter were assigned to receive either an antibiotic-heparin lock solution (antibiotic group: cefazolin 10 mg/ml, gentamicin 5 mg/ml, heparin 1,000 U/ml) or a heparin lock solution (no-antibiotic group: heparin 1,000 U/ml) as a catheter lock solution during the interdialytic period. The present study aimed to assess the efficacy of ALT using cefazolin and gentamicin in reducing CRB in patients undergoing HD with tunneled central catheter and to identify its adverse effects. CRB developed in 32.4 % of patients in the no-antibiotic group and in 13.1 % of patients in the antibiotic group. CRB rates per 1,000 catheter-days were 0.57 in the antibiotic group versus 1.74 in the no-antibiotic group (p < 0.0001). Kaplan-Meier analysis also showed that mean CRB-free catheter survival was significantly higher in the antibiotic group than in the no-antibiotic group (log-rank statistic 17.62, p < 0.0001). There was statistically significant difference between the two groups in causative organisms of CRB, with predominance of negative culture in both groups, but this prevalence was higher in ALT group (57.9 vs 90.1 %, p < 0.0001), and the two groups also were different in prevalence of gram-positive bacteria as causing organisms (ALT group 21.05 vs = 0 % in control group, p < 0.0001). There was no statistically significant difference between the two groups in drug-resistant germs. There were statistically significant differences between the two groups in the catheter removal causes, with higher rate of infectious cause in control group (12.32 vs 2.22 %, p < 0.0001) and mechanical cause in ALT group (28.26 vs 37.78 %, p < 0.0001). The results suggest that ALT may be a beneficial means of reducing the CRB rate in HD patients with tunneled catheter, without association between ALT and emergence of strains resistant. However, mechanical complications were more prevalent in antibiotic group. Further studies are required to determine the optimal drug regimen, concentrations for ALT, and its adverse effects.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23269457     DOI: 10.1007/s11255-012-0339-1

Source DB:  PubMed          Journal:  Int Urol Nephrol        ISSN: 0301-1623            Impact factor:   2.370


  30 in total

1.  An in vitro evaluation of the antibiotic/heparin lock to sterilize central venous haemodialysis catheters.

Authors:  Lavern M Vercaigne; Sheryl A Zelenitsky; Ian Findlay; Keevin Bernstein; S Brian Penner
Journal:  J Antimicrob Chemother       Date:  2002-04       Impact factor: 5.790

2.  Bacterial infections in hemodialysis patients: pathogenesis and prevention.

Authors:  Bertrand L Jaber
Journal:  Kidney Int       Date:  2005-06       Impact factor: 10.612

3.  Clinical practice guidelines for vascular access.

Authors: 
Journal:  Am J Kidney Dis       Date:  2006-07       Impact factor: 8.860

4.  Elimination of intraluminal colonization by antibiotic lock in silicone vascular catheters.

Authors:  D A Andris; E A Krzywda; C E Edmiston; C J Krepel; C M Gohr
Journal:  Nutrition       Date:  1998-05       Impact factor: 4.008

5.  Sodium citrate 4% locking solution for central venous dialysis catheters--an effective, more cost-efficient alternative to heparin.

Authors:  Linda Grudzinski; Patricia Quinan; Sophie Kwok; Andreas Pierratos
Journal:  Nephrol Dial Transplant       Date:  2006-10-25       Impact factor: 5.992

6.  National surveillance of dialysis-associated diseases in the United States, 2002.

Authors:  Lyn Finelli; Jeremy T Miller; Jerome I Tokars; Miriam J Alter; Matthew J Arduino
Journal:  Semin Dial       Date:  2005 Jan-Feb       Impact factor: 3.455

7.  A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.

Authors:  John Moran; Sumi Sun; Ishrag Khababa; Alexander Pedan; Sheila Doss; Brigitte Schiller
Journal:  Am J Kidney Dis       Date:  2011-11-14       Impact factor: 8.860

8.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

9.  Preventing haemodialysis catheter-related bacteraemia with an antimicrobial lock solution: a meta-analysis of prospective randomized trials.

Authors:  Laura Labriola; Ralph Crott; Michel Jadoul
Journal:  Nephrol Dial Transplant       Date:  2007-12-08       Impact factor: 5.992

Review 10.  Long-term management of the tunneled venous catheter.

Authors:  Orfeas Liangos; Ambreen Gul; Nicolaos E Madias; Bertrand L Jaber
Journal:  Semin Dial       Date:  2006 Mar-Apr       Impact factor: 3.455

View more
  10 in total

1.  A single institutional experience of conversion of non-tunneled to tunneled hemodialysis catheters: a comparison to de novo placement.

Authors:  Sunil Kumar Bajaj; Joseph Ciacci; Matthias Kirsch; John D Ebersole
Journal:  Int Urol Nephrol       Date:  2013-07-23       Impact factor: 2.370

Review 2.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis
Journal:  Cochrane Database Syst Rev       Date:  2022-07-18

Review 3.  Antibiotic lock therapy: review of technique and logistical challenges.

Authors:  Julie Ann Justo; P Brandon Bookstaver
Journal:  Infect Drug Resist       Date:  2014-12-12       Impact factor: 4.003

4.  Risk factors for catheter-related infections in patients receiving permanent dialysis catheter.

Authors:  Fani Delistefani; Manuel Wallbach; Gerhard A Müller; Michael J Koziolek; Clemens Grupp
Journal:  BMC Nephrol       Date:  2019-05-31       Impact factor: 2.388

5.  Vancomycin-lock therapy for prevention of catheter-related bloodstream infection in very low body weight infants.

Authors:  Hong Liang; Lian Zhang; Xiaoping Guo; Li Sun
Journal:  BMC Pediatr       Date:  2021-01-04       Impact factor: 2.125

6.  Initial Clinical Experience with a Symmetric Tip Tunneled Hemodialysis Catheter Without Side Holes.

Authors:  Michael G Tal; Alexander S Yevzlin
Journal:  ASAIO J       Date:  2021-11-01       Impact factor: 2.872

7.  Physical Compatibility, Antimicrobial Activity, and Stability of Cefazolin Combined with Gentamicin or Ethanol in Sodium Citrate as a Catheter Lock Solution.

Authors:  Rinda Devi Bachu; Akshith Dass; Emily To; Sai H S Boddu; Rose Jung; Mariann D Churchwell
Journal:  J Pharm Bioallied Sci       Date:  2021-11-24

Review 8.  Reevaluation of lock solutions for Central venous catheters in hemodialysis: a narrative review.

Authors:  Yiqin Wang; Xuefeng Sun
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

Review 9.  Heparin versus 0.9% sodium chloride locking for prevention of occlusion in central venous catheters in adults.

Authors:  Eduardo López-Briz; Vicente Ruiz Garcia; Juan B Cabello; Sylvia Bort-Martí; Rafael Carbonell Sanchis; Amanda Burls
Journal:  Cochrane Database Syst Rev       Date:  2018-07-30

10.  Extended daily dialysis in acute kidney injury patients: metabolic and fluid control and risk factors for death.

Authors:  Daniela Ponce; Juliana Maria Gera Abrão; Bianca Ballarin Albino; André Luis Balbi
Journal:  PLoS One       Date:  2013-12-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.